Aarti Drugs Files BRSR for FY 2025-26

Aarti Drugs Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the Financial Year 2025-26, as per SEBI regulations. The report details the company's corporate identity, registered and corporate addresses, contact information, and financial year reporting period. It covers business activities, primarily manufacturing and marketing of pharmaceuticals and chemical products, which account for 100% of turnover. Key products include APIs (89% of turnover), specialty chemicals (8%), and intermediates (3%). The company operates 13 plants and 2 offices nationally, serving 28 states and 8 union territories, with exports contributing approximately 38% of revenue to over 100 countries. Employee details as of March 31, 2026, show a total of 1496 employees and 1335 workers. The BRSR is available on the company's website.